Role of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell Invasion
Open Access
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (12) , 4833-4842
- https://doi.org/10.1158/0008-5472.can-08-0644
Abstract
Heat shock protein (hsp) 90 is an ATP-dependent molecular chaperone that maintains the active conformation of client oncoproteins in cancer cells. An isoform, hsp90α, promotes extracellular maturation of matrix metalloproteinase (MMP)-2, involved in tumor invasion and metastasis. Knockdown of histone deacetylase (HDAC) 6, which deacetylates lysine residues in hsp90, induces reversible hyperacetylation and attenuates ATP binding and chaperone function of hsp90. Here, using mass spectrometry, we identified seven lysine residues in hsp90α that are hyperacetylated after treatment of eukaryotic cells with a pan-HDAC inhibitor that also inhibits HDAC6. Depending on the specific lysine residue in the middle domain involved, although acetylation affects ATP, cochaperone, and client protein binding to hsp90α, acetylation of all seven lysines increased the binding of hsp90α to 17-allyl-amino-demethoxy geldanamycin. Notably, after treatment with the pan-HDAC inhibitor panobinostat (LBH589), the extracellular hsp90α was hyperacetylated and it bound to MMP-2, which was associated with increased in vitro tumor cell invasiveness. Treatment with antiacetylated hsp90α antibody inhibited in vitro invasion by tumor cells. Thus, reversible hyperacetylation modulates the intracellular and extracellular chaperone function of hsp90, and targeting extracellular hyperacetylated hsp90α may undermine tumor invasion and metastasis. [Cancer Res 2008;68(12):4833–42]Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregatesGenes & Development, 2007
- Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of CarcinogenesisCell, 2007
- Extracellular heat shock protein-90α: linking hypoxia to skin cell motility and wound healingThe EMBO Journal, 2007
- An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone FunctionPublished by Elsevier ,2007
- p53 mediates the negative regulation of MDM2 by orphan receptor TR3The EMBO Journal, 2006
- Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activationProceedings of the National Academy of Sciences, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3Blood, 2005
- Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasivenessNature Cell Biology, 2004
- Induction of Hsp90 protein expression in malignant melanomas and melanoma metastasesExperimental Dermatology, 2004